Charles River Labs To Provide Western-Standard GLP Services in China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Charles River Laboratories is expanding its operations in China with Western-standard discovery and good laboratory practice services that will enable it to conduct studies suitable to submit to regulators in the U.S., Europe and China, the company said Feb 20
You may also be interested in...
Charles River Laboratories VP Christopher Perkins On Building Preclinical Facilities In China: An Interview With PharmAsia News (Part 1 of 2)
Wilmington, Mass.-based contract research organization Charles River Laboratories offers drug discovery and development services to global pharmaceutical and biotechnology companies, government agencies, and leading academic institutions. Senior VP Christopher Perkins recently spoke with PharmAsia News about the company's operations in China and the landscape there for preclinical services.
Charles River Laboratories VP Christopher Perkins On Building Preclinical Facilities In China: An Interview With PharmAsia News (Part 1 of 2)
Wilmington, Mass.-based contract research organization Charles River Laboratories offers drug discovery and development services to global pharmaceutical and biotechnology companies, government agencies, and leading academic institutions. Senior VP Christopher Perkins recently spoke with PharmAsia News about the company's operations in China and the landscape there for preclinical services.
PharmAsia News Notable Notes: China’s Outsourcing Costs Vs. Growth Potential
Analysts' views on the costs associated with outsourcing research to China remains mixed, but concerns regarding fluctuations in costs are minimized by opportunity for growth in China, according to Baird analyst Eric Coldwell